Abstract:AIM To investigate the expression of miR-210 and the role it plays in the cell cycle to regulate radioresistance in oesophageal squamous cell carcinoma (ESCC). METHODS MiR-210 expression was evaluated in 37 pairs of ESCC tissues and matched para-tumorous normal oesophageal tissues from surgical patients who had not received neoadjuvant therapy, and in the cells of two novel radioresistant cell lines, TE-1R and Eca-109R, using quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The transient up-regulation of miR-210 expression in TE-1R and Eca-109R cells was studied using liposomes and was confirmed using qRT-PCR. The rate of cell survival after a series of radio-treatment doses was evaluated using the clone formation assay. Flow cytometry was used to detect the changes to the cell cycle patterns due to radiation treatment. RT-PCR and Western blot were used to detect the expression of ataxia telangiectasia mutated (ATM) and DNA dependent protein kinase (DNA-PKcs) after irradiation, and the cell sphere formation assay was used to evaluate the proliferative ability of the cancer stem-like cells. RESULTS The level of miR-210 expression was significantly decreased, by 21.3% to 97.2%, with the average being 39.2% ± 16.1%, in the ESCC tissues of most patients (81.1%, 30 of 37 vs patients with high miR-210 expression, P < 0.05). A low level of expression of miR-210 was correlated with a poorly differentiated pathological type (P < 0.01) but was not correlated with the T-stage or lymph node infiltration (both P > 0.05). Early local recurrences (< 18 mo, n = 19) after radiotherapy were significantly related with low miR-210 expression (n = 13, P < 0.05). The level of miR-210 was decreased by approximately 73% (vs TE-1, 0.27 ± 0.10, P < 0.01) in the established radioresistant TE-IR cell line and by 52% (vs Eca-109, 0.48 ± 0.17, P < 0.05) in the corresponding Eca-109R line. Transient transfection with a miR-210 precursor increased the level of miR-210 expression, leading to a significant increase in cell survival after radiotherapy (P < 0.05). Twenty-four hours after radiation, the proportion of pmiR-210 cells in S phase was increased (vs control cells, 30.4% ± 0.4%, and vs untreated TE-1R cells, 23.3% ± 0.7%, P < 0.05 for both). The levels of DNA-PKcs (0.21 ± 0.07) and ATM (0.12 ± 0.03, P < 0.05) proteins were significantly lower in the PmiR-210 cells than in control cells, but no differences were found in the levels of the corresponding mRNAs in the two cell types (P > 0.05 for all). Exogenous miR-210 expression decreased the diameter of pmiR-210 cell spheres (vs control cells, 0.60 ± 0.14, P < 0.05). CONCLUSION MiR-210 expression is negatively correlated with the pathological type and the local survival rate after radiotherapy, and high expression of miR-210 may reverse the radioresistance of ESCC stem-like cells.

Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro.

Effects of mir-210 anti-sense lentivirus on radiosensitivity of hypoxic human hepatoma cells

Anti-tumor effects of knockdown miR-210 combined with radiotherapy on human hepatoma xenograft in nude mice

Lncrna MIR22HG-Derived Mir-22-5p Enhances the Radiosensitivity of Hepatocellular Carcinoma by Increasing Histone Acetylation Through the Inhibition of HDAC2 Activity

Effects of Knockdown of Mir-210 in Combination with Ionizing Radiation on Human Hepatoma Xenograft in Nude Mice

Hypoxia-Inducible Factor-1 Alpha Downregulation By Small Interfering Rna Inhibits Proliferation, Induces Apoptosis, And Enhances Radiosensitivity In Chemical Hypoxic Human Hepatoma Smmc-7721 Cells

Knockdown of Mir-210 Decreases Hypoxic Glioma Stem Cells Stemness and Radioresistance

Effects of hypoxia on the expressions of hypoxia-inducible factor-1 alpha and miR-210 in hepatocellular carcinoma HepG2 cells

MicroRNA‑210 negatively regulates the radiosensitivity of nasopharyngeal carcinoma cells

miR-210 loss leads to widespread phenotypic and gene expression changes in human 293T cells

MicroRNA-210 Promotes Cancer Angiogenesis by Targeting Fibroblast Growth Factor Receptor-Like 1 in Hepatocellular Carcinoma.

LincRNA-p21 Knockdown Enhances Radiosensitivity of Hypoxic Tumor Cells by Reducing Autophagy Through HIF-1/Akt/mTOR/P70S6K Pathway

Radiosensitizing Effects of Mir‐18a‐5p on Lung Cancer Stem‐like Cells Via Downregulating Both ATM and HIF‐1α

Hypoxia-Inducible Microrna-210 Augments the Metastatic Potential of Tumor Cells by Targeting Vacuole Membrane Protein 1 in Hepatocellular Carcinoma

Hypoxia-induced Autophagy Reduces Radiosensitivity by the HIF-1α/miR-210/Bcl-2 Pathway in Colon Cancer Cells

Radiation-induced Mir-208A Increases the Proliferation and Radioresistance by Targeting P21 in Human Lung Cancer Cells.

MiR-210 Expression Reverses Radioresistance of Stem-Like Cells of Oesophageal Squamous Cell Carcinoma.

Up-regulation of microRNA153 causes radio-sensitization of lung cancer cells in vitro experiments

MicroRNA-203 increase cell radiosensitivity via directly targeting Bmi-1 in hepatocellular carcinoma.

Effects of MicroRNA-195-5p on Biological Behaviors and Radiosensitivity of Lung Adenocarcinoma Cells Via Targeting HOXA10

MicroRNA-218 Enhances the Radiosensitivity of Human Cervical Cancer Via Promoting Radiation Induced Apoptosis.